GSK plc Cash Flows From Used In Investing Activities
GSK plc (GLAXF) reported Cash Flows From Used In Investing Activities of -GBP 4.23 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-03-06
| Period end | Cash Flows From Used In Investing Activities 12 month |
|---|---|
| 2025-12-31 | -4.23B GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | -1.23B GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | -1.59B GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | -8.77B GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | -1.78B GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | 2.16B GBP 20-F · filed 2023-03-10 |
| 2019-12-31 | -5.35B GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | -1.55B GBP 20-F · filed 2021-03-12 |
| 2017-12-31 | -1.44B GBP 20-F · filed 2020-03-06 |
| 2016-12-31 | -1.27B GBP 20-F · filed 2019-03-15 |
| 2015-12-31 | 6.04B GBP 20-F/A · filed 2018-03-20 |